Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of this study is to examine the effects of bilateral sphenopalatine ganglion block on surgical conditions, hemodynamics, intraoperative and postoperative analgesic use, recovery characteristics, and postoperative pain during septorhinoplasty under general anesthesia. The study was planned as double-blind, randomized, controlled. 72 patients who will undergo septorhinoplasty surgery will be collected. (g power analysis was performed.) Evaluation of the effectiveness of bilateral sphenopalatine ganglion block was planned. Patients will be divided into 2 equal groups (36 patients). After the induction of general anesthesia, one group (Group: 1) will be administered 8mg dexamethasone and 10mg bupivacaine submucosal, the other group (group:2) will be administered 4 cc saline. aspects will be evaluated.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Endoscopic bilateral sphenopalatine ganglion block | Active Comparator | After the induction of general anesthesia, one group (Group: 1) will be administered 8mg dexamethasone and 10mg bupivacaine submucosal, |
|
| Placebo | Placebo Comparator | Placebo group (group:2) will be administered 4 cc saline. aspects will be evaluated. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Bilateral endoscopic sphenopalatine ganglion block | Procedure | After the induction of general anesthesia, one group (Group: 1) will be administered 8mg dexamethasone and 10mg bupivacaine submucosal, |
| Measure | Description | Time Frame |
|---|---|---|
| Numeric Rating Scale | They will be numbered from 1 to 10. 1 mildest 10 most severe pain | Postoperative 0-2 hours, 2-8 hours,8-24 hours |
| Measure | Description | Time Frame |
|---|---|---|
| Riker Agitation Scale | 7 Dangerous Agitation 6 Very Agitated 5 Agitated 4 Calm and Cooperative 3 sedated 2 Very Sedated A 1 Unarousable | Immediately after extubation |
| mean arterial pressure | mmhg |
Not provided
Inclusion Criteria:
- patients with an ASA score of I-II and between the ages of 17-45 years, who were to undergo general anesthesia with desflurane, were included in the study.
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Health Sciences University Gazi Yaşargil Training and Research Hospital | Diyarbakır | Kayapınar | 21070 | Turkey (Türkiye) |
Not provided
Not provided
Not provided
Not provided
Not provided
| Type | Date | Date Unknown |
|---|---|---|
| Release | Feb 26, 2024 | |
| Reset | Aug 7, 2024 |
Not provided
Not provided
Not provided
Not provided
Not provided
| placebo | Procedure | Placebo group (group:2) will be administered 4 cc saline. aspects will be evaluated. |
|
| when you come to the operating room table after anesthesia induction Intraoperative 30 minutes after extubation |
| heart rate | beats\minute | when you come to the operating room table after anesthesia induction Intraoperative 30 minutes after extubation |
| intraoperative remifentanil consumption | The intraoperative ultiva infusion dose was recorded to the patient. | intraoperative |
| edema questionnaire | Periorbital edema was evaluated as present or absent questionnaire | Postoperative 0-2 hours, 2-8 hours,8-24 hours |
| hematoma questionnaire | Hematoma was evaluated as present or absent questionnaire | Postoperative 0-2 hours, 2-8 hours,8-24 hours |
| vomiting questionnaire | was evaluated as present or absent questionnaire | Postoperative 0-2 hours, 2-8 hours,8-24 hours |
| Oral analgesic use | Analgesic use in the first 24 hours was questioned. | In the first 24 hours after surgery |
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| Feb 26, 2024 | Aug 7, 2024 |